Related Experiment Video

Updated: May 24, 2025

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
06:43

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 7, 2013

13.7K

The Role of Lipoprotein(a) in the Progression of Aortic Stenosis

Clay Sherrill1, Lauren Ehrhardt-Humbert1, Deeb Salem2

  • 1Department of Medicine, Tufts Medical Center, Boston, Mass.

The American Journal of Medicine
|March 6, 2025
PubMed

Insights

Lipoprotein (a) drives calcific aortic stenosis progression. New RNA-based therapies aim to lower Lp(a) levels, but their impact on aortic stenosis and cardiovascular outcomes requires further study.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Pharmacology

Background:

  • Calcific aortic stenosis (CAS) is a complex, lifelong process influenced by genetics, lipids, inflammation, and stress.
  • Lipoprotein (a) [Lp(a)] is a key driver of CAS progression, linked to earlier onset and faster hemodynamic deterioration.
  • Standard lipid-lowering drugs do not effectively reduce Lp(a) levels.

Purpose of the Study:

  • To review emerging therapeutics targeting serum Lp(a) reduction.
  • To explore the potential of novel treatments, including RNA-based modifications, for managing CAS.
  • To assess the correlation between Lp(a) lowering and improved cardiovascular outcomes.

Main Methods:

  • Review of current scientific literature and clinical studies.
  • Analysis of genetic and lipid-related factors in CAS.
  • Examination of novel therapeutic strategies for Lp(a) management.

Main Results:

  • Lp(a) is a significant factor in the development and progression of aortic stenosis.
  • Existing treatments for low-density lipoprotein do not impact Lp(a) levels.
  • Several novel therapies, particularly those using ribonucleic acid modification, are in development to lower Lp(a).

Conclusions:

  • Novel Lp(a)-lowering therapies show promise for managing calcific aortic stenosis.
  • Further research is needed to confirm if reducing serum Lp(a) translates to better cardiovascular health and reduced CAS.
  • Understanding the role of Lp(a) is critical for developing effective treatments for aortic stenosis.

Keywords:
Aortic calcificationAortic stenosisHyperlipidemiaLipoprotein (a)

More Related Videos

A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium11:00

A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium

Published on: June 22, 2010

28.4K
Imaging and Analysis of Oil Red O-Stained Whole Aorta Lesions in an Aneurysm Hyperlipidemia Mouse Model07:57

Imaging and Analysis of Oil Red O-Stained Whole Aorta Lesions in an Aneurysm Hyperlipidemia Mouse Model

Published on: May 2, 2022

12.8K

Related Concept Videos

Inflammation01:38

Inflammation

Overview
52.2K
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
4.3K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
501
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
492
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
914